Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension.
The Lancet regional health. Europe · 2026 Sep
Kidney biology papers selected after physician review, with emphasis on mechanisms, fibrosis, inflammation, aging, tubular injury, omics, biomarkers, and translational science.
Published 2026-07-20 after physician review. 20 items selected for this lane.
The Lancet regional health. Europe · 2026 Sep
Cell death & disease · 2026 Jul 18
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026 Jul 18
Nature communications · 2026 Jul 17
Cell death discovery · 2026 Jul 17
Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026 Jul 17
Human cell · 2026 Jul 19
Journal of the American Society of Nephrology : JASN · 2026 Jul 17
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026 Jul 18
Renal failure · 2026 Dec
Transplantation reviews (Orlando, Fla.) · 2026 Jul 15
Biochemical and biophysical research communications · 2026 Jul 16
Medicine · 2026 Jul 17
Biology direct · 2026 Jul 17
Biochemical pharmacology · 2026 Jul 19
BMC nephrology · 2026 Jul 19
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026 Jul 7
Medicine · 2026 Jul 17
Genome research · 2026 Jul 17
BMJ case reports · 2026 Jul 17